©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Oct 27, 2024; 16(10): 1208-1212
Published online Oct 27, 2024. doi: 10.4254/wjh.v16.i10.1208
Published online Oct 27, 2024. doi: 10.4254/wjh.v16.i10.1208
Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective
Nabil Eid, Department of Anatomy, Division of Human Biology, School of Medicine, IMU University, Kuala Lumpur 57000, Malaysia
Payal Bhatnagar, Department of Pharmaceutical Technology, School of pharmacy, IMU University, Kuala Lumpur 57000, Malaysia
Li-Li Chan, Department of Pathology and Pharmacology, School of Medicine, IMU University, Kuala Lumpur 57000, Malaysia
Marina Garcia-Macia, Institute of Functional Biology and Genomics, Department of Biochemistry and Molecular Biology, University of Salamanca, Salamanca 37007, Spain
Author contributions: Eid N wrote and approved the final draft of the manuscript; Bhatnagar P designed the figure; Chan LL revised the text and the artwork; Garcia-Marina M revised the manuscript; All authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Nabil Eid, PhD, Academic Editor, Affiliate Associate Professor, Department of Anatomy, Division of Human Biology, School of Medicine, IMU University, Bukit Jalil, Kuala Lumpur 57000, Malaysia. nabilsaleheid@imu.edu.my
Received: July 10, 2024
Revised: September 24, 2024
Accepted: October 11, 2024
Published online: October 27, 2024
Processing time: 102 Days and 21.5 Hours
Revised: September 24, 2024
Accepted: October 11, 2024
Published online: October 27, 2024
Processing time: 102 Days and 21.5 Hours
Core Tip
Core Tip: Modified Xiaoyao San (MXS) formula has hepato-protective effects in a male rat model of non-alcoholic steatohepatitis (NASH) via suppression of steatosis and inflammation. These protective effects are related to several mechanisms, including the regulation of sex hormone metabolism, androgen upregulation, adenosine 5’-monophosphate-activated protein kinase activation, and enhanced phosphatase and tensin homolog expression. A deeper understanding of the mechanisms behind MXS-induced reduction of hepatic steatosis could assist in the treatment of NASH and related diseases.